Edwards Lifesciences
1,213 hedge funds and large institutions have $37.5B invested in Edwards Lifesciences in 2024 Q4 according to their latest regulatory filings, with 188 funds opening new positions, 348 increasing their positions, 498 reducing their positions, and 140 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,213
Holders Change
+30
Holders Change %
+2.54%
% of All Funds
16.15%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
188
Increased
348
Reduced
498
Closed
140
Calls
$586M
Puts
$264M
Net Calls
+$322M
Net Calls Change
-$115M
Top Buyers
| 1 |
Jennison Associates
New York
|
$556M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$697M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.12B |
| 4 |
JPMorgan Chase & Co
New York
|
$1.1B |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$314M |
